For the current week, the overall ratings of five Medical Devices stocks are worse, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
CryoLife (NYSE:CRY) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. CryoLife preserves and distributes human tissues in addition to developing, manufacturing, and commercializing medical devices for cardiac and vascular transplant applications. CRY also rates an F in Portfolio Grader’s specific subcategory of Earnings Momentum. For more information, get Portfolio Grader’s complete analysis of CRY stock.
Volcano (NASDAQ:VOLC) earns a D this week, moving down from last week’s grade of C. Volcano designs, develops, manufactures and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products that enhance the diagnosis and treatment of vascular and structural heart disease. The stock also gets an F in Earnings Momentum. The stock has a trailing PE Ratio of 42.8. VOLC shares are down 8% for the past month. To get an in-depth look at VOLC, get Portfolio Grader’s complete analysis of VOLC stock.
Hansen Medical (NASDAQ:HNSN) earns an F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). Hansen Medical develops and manufactures medical robotics designed for positioning, manipulation, and control of catheters and catheter-based technologies. The stock receives F’s in Earnings Growth, Earnings Momentum, and Equity. Cash Flow and Sales Growth also get F’s. Wall Street appears to agree with the stock downgrade, with share prices dropping 33% over the past month. As of Aug. 13, 16.4% of outstanding Hansen Medical shares were held short. For a full analysis of HNSN stock, visit Portfolio Grader.
Rockwell Medical Inc‘s (NASDAQ:RMTI) rating weakens this week, dropping to a D versus last week’s C. Rockwell Medical Technologies manufactures hemodialysis concentrate solutions and dialysis kits. The stock gets F’s in Equity, Cash Flow, and Sales Growth. The stock price has fallen 5.5% over the past month. For more information, get Portfolio Grader’s complete analysis of RMTI stock.
Alphatec Holdings (NASDAQ:ATEC) is having a tough week. The company’s rating falls from a D to an F rating. Alphatec Holdings designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, primarily focusing on the aging spine in the United States and internationally. The stock gets F’s in Earnings Revisions, Equity, and Cash Flow. Share prices fell 13.3% over the past month. For a full analysis of ATEC stock, visit Portfolio Grader.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.